Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00246532 · ClinicalTrials.gov registry record · Phase 4
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
A Phase 4 study, sponsored by National Institute of General Medical Sciences (NIGMS).
- Completed
- Registry status
- Phase 4
- Development phase
- 139
- Enrollment target
NCT00246532 is a Phase 4 study that has completed, run by National Institute of General Medical Sciences (NIGMS). The registered enrollment target is 139 participants.
The verdict
NCT00246532, a Phase 4 study, has completed, sponsored by National Institute of General Medical Sciences (NIGMS).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 139 participants
- Enrollment target
Study Summary
Opiates such as morphine are the cornerstone medications for the treatment of moderate to severe pain. Recent evidence suggests that pain patients on chronic opioid therapy become more sensitive to pain (hyperalgesia) over time. There is also a long-standing notion that analgesic tolerance to opioids (habituation) develops during chronic use even though this phenomenon has never been prospectively studied. Our specific aims propose to prospectively test the hypotheses that; 1) Pain patients on chronic opioid therapy develop dose-dependent tolerance and/or hyperalgesia to these medications over time, 2) Opioid-induced tolerance and hyperalgesia develop differently with respect to various types of pain, 3) Opioid-induced hyperalgesia occurs independently of withdrawal phenomena, and 4) Opioid-induced tolerance and hyperalgesia develop differently based on gender and/or ethnicity. This proposed study will be the first quantitative and prospective study of tolerance and hyperalgesia in pain patients and will have important implications for the rational use of opioids in the treatment of chronic pain.
Interventions
- DRUG Placebo
- DRUG Morphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2005-10 |
| Est. Completion | 2009-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00246532
The ClinicalTrials.gov registry entry for NCT00246532 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of General Medical Sciences (NIGMS), which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00246532 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00246532 about?
NCT00246532 is a clinical study titled "Opiate-Induced Tolerance & Hyperalgesia in Pain Patients". Opiates such as morphine are the cornerstone medications for the treatment of moderate to severe pain. Recent evidence suggests that pain patients on chronic opioid therapy become more sensitive to pain (hyperalgesia) over time. There is also a long-standing notion that analgesic tolerance to opioid...
What is the current status of trial NCT00246532?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 139 participants. The study started on 2005-10. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00246532?
The interventions under investigation include: Placebo (DRUG), Morphine (DRUG).
Who is sponsoring clinical trial NCT00246532?
This trial is sponsored by National Institute of General Medical Sciences (NIGMS), which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.